gentamicin has been researched along with penicillanic acid in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (17.74) | 18.7374 |
1990's | 15 (24.19) | 18.2507 |
2000's | 14 (22.58) | 29.6817 |
2010's | 21 (33.87) | 24.3611 |
2020's | 1 (1.61) | 2.80 |
Authors | Studies |
---|---|
Calia, FM; Hornick, RB; Standiford, HC; Tatem, BA; Wald, ER | 1 |
Bure, A; Carbon, C; Jehl, F; Mentec, H; Saleh-Mghir, A; Vallois, JM | 1 |
Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B | 1 |
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Riggio, CE; Yellin, AE | 1 |
Crombleholme, W; Dahrouge, D; DeKay, V; Hadley, WK; Landers, D; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
Gunning, J | 1 |
Crombleholme, WR; DeKay, V; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
Bannister, T; Watanakunakorn, C | 1 |
Cushing, RD; Lerner, AM; Williams, BB | 1 |
Cagle, GD; Schlech, BA | 1 |
Durack, DT; Washburn, RG | 1 |
Green, EA; Hall, S; Hanna, CE; Sattler, FR | 1 |
Baumgärtner, M; Müller, HP; Wundt, W | 1 |
Lahnborg, G; Nord, CE | 1 |
Liu, CY; Lui, WY; Shyr, YM; Su, CH; Wang, LS | 1 |
Duval, J; Leclercq, R | 1 |
Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL | 1 |
Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
Arpi, M; Bruun, B; Gottschau, A; Mortensen, I; Victor, MA | 1 |
Bowker, KE; Hedges, AJ; Holt, HA; MacGowan, AP; Reeves, DS; Wootton, M | 1 |
Arredondo-Garcia, JL; Figueroa-Damian, R; San Martín-Herrasti, JM; Villagrana-Zesati, R | 1 |
Gould, IM; Milne, K | 1 |
Hitt, CM; Nicolau, DP; Nightingale, CH; Patel, KB; Zhu, Z | 1 |
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N | 1 |
Grossenbacher, M; Imhof, E; Speich, R; Vogt, M; Zimmerli, W | 1 |
Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B | 1 |
Dul, MJ; Hoyen, C; Salvator, A; Toltzis, H; Toltzis, P; Walsh, M; Zetts, L | 2 |
Minami, S; Takahata, M; Yamada, H | 1 |
Gilsdorf, JR | 1 |
Burgess, DS; Nathisuwan, S | 1 |
Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C | 1 |
Ford, HR; Gaines, BA; Nadler, EP; Reblock, KK | 1 |
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M | 1 |
Crinnion, JN; Pencavel, TD; Singh-Ranger, G | 1 |
Elsayed, S; Zhang, K | 1 |
Artini, M; Di Clemente, D; Palma, S; Papa, R; Scoarughi, GL; Selan, L; Veeh, R | 1 |
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
Cho, B; Im, SA; Park, GS; Yun, DY | 1 |
Aziz, MN; Desa, MN; Idris, SN; Taib, NM | 1 |
Bloom, BT; Chong, E; Delmore, P; Forur, L; Gordon, P; Reynolds, J; Shaw, J; Uner, H | 1 |
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
Chan, MC; Chang, FY; Lee, Y; Lin, JC; Lin, TY; Yang, YS; Yeh, KM | 1 |
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
Bartoletti, R; Bjerklund Johansen, TE; Brugnolli, A; Cai, T; Eccher, C; Lanzafame, P; Luciani, LG; Malossini, G; Mirone, V; Pickard, R; Tiscione, D; Verze, P; Wagenlehner, FM | 1 |
Bagan, P; Couffinhal, JC; Dakhil, B; Gordienco, A; Hernigou, J; Longuet, P | 1 |
Amornchai, P; Day, NPJ; Langla, S; Limmathurotsakul, D; Peacock, SJ; White, NJ; Wuthiekanun, V | 1 |
Afzelius, P; Bergmann, A; Henriksen, JH | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Bartlett, CS; Groth, ME; McMillian, WD; Redfern, J; Wasilko, SM | 1 |
Chen, Y; Gao, W; Li, X; Ouyang, W; Wei, J; Wen, Z; Xue, H | 1 |
Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M | 1 |
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS | 1 |
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ | 1 |
Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
Heather, CS; Maley, M | 1 |
Bischoff, S; Ebert, M; Gerigk, M; Vogelmann, R; Walter, T | 1 |
Arnaud, A; Costet, N; Donnio, PY; Engrand, C; Habonimana, E; Nardi, N; Taleb, M; Tattevin, P; Wodey, E | 1 |
Dhamija, P; Goyal, T; Gupta, P; Trikha, V; Vardhan, G | 1 |
15 trial(s) available for gentamicin and penicillanic acid
Article | Year |
---|---|
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.
Topics: Adult; Ampicillin; Appendicitis; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Gangrene; Gentamicins; Humans; Intestinal Perforation; Male; Penicillanic Acid; Peritonitis; Prospective Studies; Pseudomonas; Pseudomonas Infections; Random Allocation; Rupture, Spontaneous; Sulbactam | 1985 |
Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cellulitis; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Metronidazole; Pelvic Inflammatory Disease; Penicillanic Acid; Peritonitis; Prospective Studies; Random Allocation; Sulbactam | 1986 |
A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Pelvic Inflammatory Disease; Penicillanic Acid; Random Allocation; Sulbactam | 1986 |
Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
Topics: Ampicillin; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Female; Genital Diseases, Female; Gentamicins; Humans; Metronidazole; Penicillanic Acid; Prospective Studies; Random Allocation; Sulbactam | 1987 |
Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Random Allocation; Tobramycin | 1983 |
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Topics: Abdomen; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1995 |
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
[Comparison of the therapeutic efficacy of the piperacillin/tazobactame combination vs. ampicillin and gentamycin in in the management of post-cesarean endometritis].
Topics: Adolescent; Adult; Age Factors; Ampicillin; Anti-Bacterial Agents; Cesarean Section; Drug Therapy, Combination; Endometritis; Enzyme Inhibitors; Female; Gentamicins; Humans; Parity; Penicillanic Acid; Penicillins; Piperacillin; Pregnancy; Tazobactam | 1996 |
Influence of piperacillin-tazobactam on pharmacokinetics of gentamicin given once daily.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Gentamicins; Half-Life; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1997 |
Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome | 2001 |
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Outcome | 2003 |
47 other study(ies) available for gentamicin and penicillanic acid
Article | Year |
---|---|
BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
Topics: Carbenicillin; Drug Combinations; Gentamicins; Guanidines; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Ticarcillin | 1975 |
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rabbits; Tazobactam | 1992 |
Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
Topics: Carbenicillin; Colony Count, Microbial; Diffusion; Drug Synergism; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa | 1974 |
Letter: Severe combined nephrotoxicity of BL-P1654 and gentamicin.
Topics: Adult; Blood Bactericidal Activity; Carbenicillin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Kidney Diseases; Penicillanic Acid; Polymyxins; Pseudomonas aeruginosa; Sepsis | 1974 |
Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Drug Evaluation, Preclinical; Female; Gentamicins; Keratitis; Male; Penicillanic Acid; Pseudomonas aeruginosa; Rabbits; Staphylococcus aureus; Streptococcus pneumoniae | 1984 |
Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
Topics: Ampicillin; Animals; beta-Lactamase Inhibitors; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Nafcillin; Penicillanic Acid; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 1981 |
[Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefsulodin; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Netilmicin; Penicillanic Acid; Sulbactam | 1983 |
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1994 |
[Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Enzyme Inhibitors; Gentamicins; Humans; In Vitro Techniques; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam; Ticarcillin | 1995 |
In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ceftazidime; Ciprofloxacin; Enzyme Inhibitors; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas | 1996 |
A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone.
Topics: Acinetobacter; Ciprofloxacin; Citrobacter freundii; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Serratia marcescens; Tazobactam | 1996 |
In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactamase Inhibitors; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gentamicins; Kinetics; Macrolides; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1997 |
Carbapenemase-producing Pseudomonas aeruginosa in UK.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom | 1998 |
Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
Topics: Anti-Bacterial Agents; Ceftazidime; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Intensive Care Units, Neonatal; Molecular Epidemiology; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 2001 |
[In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
Topics: Amikacin; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2002 |
Jet-black eschar.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy, Combination; Ecthyma; Female; Gentamicins; Humans; Infant; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections | 2002 |
The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam | 2002 |
Monotherapy versus multi-drug therapy for the treatment of perforated appendicitis in children.
Topics: Ampicillin; Appendectomy; Appendicitis; Child; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies | 2003 |
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.
Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2005 |
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome | 2005 |
Conservative treatment of an early aortic graft infection due to Acinetobacter baumanii.
Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Debridement; Female; Gentamicins; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2006 |
Isolation and 16S ribosomal RNA gene sequence-based identification of Clostridium scindens from an intra-abdominal abscess.
Topics: Abdominal Abscess; Adolescent; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Crohn Disease; Female; Gentamicins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; RNA, Ribosomal, 16S; Tomography, X-Ray Computed | 2006 |
Phosphorylcholine impairs susceptibility to biofilm formation of hydrogel contact lenses.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Coated Materials, Biocompatible; Contact Lenses, Hydrophilic; Gentamicins; Hydrogel, Polyethylene Glycol Dimethacrylate; Imipenem; Microbial Sensitivity Tests; Microscopy, Confocal; Penicillanic Acid; Phosphorylcholine; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyhydroxyethyl Methacrylate; Pseudomonas aeruginosa; Silicon; Staphylococcus epidermidis | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Necrotic intramuscular chloroma with infection: magnetic resonance imaging features.
Topics: Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Child; Contrast Media; Cytarabine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Gentamicins; Humans; Image Enhancement; Klebsiella Infections; Klebsiella pneumoniae; Leg; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Meropenem; Muscle Neoplasms; Necrosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sarcoma, Myeloid; Teicoplanin; Thienamycins; Treatment Outcome | 2011 |
Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital.
Topics: ADP Ribose Transferases; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cefepime; Ceftazidime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2012 |
Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.
Topics: Alkaline Phosphatase; Ampicillin; Apgar Score; Diaper Rash; Female; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Treatment Outcome | 2013 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Taiwan | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Europe; Female; Gentamicins; Guideline Adherence; Humans; Klebsiella; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urologic Surgical Procedures; Urology | 2016 |
[Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon].
Topics: Aged, 80 and over; Alloys; Amoxicillin; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Arteriosclerosis Obliterans; Bacteremia; Coronary Disease; Coronary Restenosis; Device Removal; Equipment Contamination; Female; Femoral Artery; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Paclitaxel; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Popliteal Artery; Propionibacterium; Prosthesis-Related Infections; Stents; Tomography, Emission-Computed, Single-Photon | 2015 |
Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Leptospira; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Abolished ventilation and perfusion of lung caused by blood clot in the left main bronchus: auto-downregulation of pulmonary arterial blood supply.
Topics: Bronchoscopy; Cough; Down-Regulation; Dyspnea; Fever; Gentamicins; Humans; Hypertension, Pulmonary; Lung; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pulmonary Embolism; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventilation-Perfusion Ratio | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Surgical Site Infections in Patients With Type 3 Open Fractures: Comparing Antibiotic Prophylaxis With Cefazolin Plus Gentamicin Versus Piperacillin/Tazobactam.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cohort Studies; Drug Combinations; Female; Fractures, Open; Gentamicins; Humans; Longitudinal Studies; Male; Middle Aged; Patient Readmission; Penicillanic Acid; Piperacillin; Prevalence; Retrospective Studies; Risk Factors; Surgical Wound Infection; Survival Rate; Tazobactam; Treatment Outcome; Vermont | 2016 |
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
Topics: Anti-Bacterial Agents; Carbapenems; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Epidemiologic Studies; Escherichia coli; Female; Gentamicins; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome | 2016 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Chlorhexidine; Drug Administration Schedule; Drug Therapy, Combination; Ether; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Liver Transplantation; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Transplant Recipients | 2016 |
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins | 2016 |
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin | 2016 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2018 |
Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Female; Fluoroquinolones; Gentamicins; Germany; Humans; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Risk Factors; ROC Curve; Tazobactam; Urinary Tract Infections | 2018 |
Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics.
Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Cefotaxime; Child; Drug Therapy, Combination; Female; Gentamicins; Guideline Adherence; Humans; Length of Stay; Male; Metronidazole; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies | 2018 |
In vitro study of elution kinetics and biological activity of piperacillin/tazobactam and gentamicin in acrylic bone cement.
Topics: Anti-Bacterial Agents; Bone Cements; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymethyl Methacrylate; Tazobactam | 2022 |